Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts

Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical sciences 1994-06, Vol.83 (6), p.763-767
Hauptverfasser: Huh, Kyongsang, Schentag, Jerome J., Wilton, John H., Nix, David E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 767
container_issue 6
container_start_page 763
container_title Journal of pharmaceutical sciences
container_volume 83
creator Huh, Kyongsang
Schentag, Jerome J.
Wilton, John H.
Nix, David E.
description Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On the basis of mass, infrared, and proton magnetic resonance spectra, the major adducts appeared to be amides formed by an attack of the B‐lactam carbonyl group of ticarcillin by an amino group of tobramycin. All other moieties of ticarcillin were intact except that the β‐lactam ring was opened and was rotated by 120–130°. The minimum inhibitory concentrations (MICs) of the adducts, tobramycin, and ticarcillin were 20.0, 0.25, and 2.0 μg/mL forStaphylococcus aureusandEscherichia coli, and 160.0, 0.5, and 8.0 μg/mL forPseudomonas aeruginosa.Thus, the major adducts possessed some antimicrobial activity, but not enough to be active in the treatment of infections. As shown by fluorescence polarization immunoassay (FPIA), the adducts demonstrate some cross‐reactivity in the assay of tobramycin. However, it was insufficient to cause significant error in the measurement of tobramycin in human serum.
doi_str_mv 10.1002/jps.2600830602
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77133020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915494985</els_id><sourcerecordid>77133020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4562-d5dcd1e8ab796a14fba556328a278f6dd0e763263da135e0a7b20311aa4406b3</originalsourceid><addsrcrecordid>eNqFkM2O0zAURi0EGkphyw4pC8Qu5dqO7WRZBugwzPCjVmJpObaD7pAmxU4GuuMR5hl5kvEoVRELxMqy7vk-Xx9CnlJYUAD28moXF0wClBwksHtkRgWDXAJV98ksASznoqgekkcxXgEkRogTclJRBiXwGTlbD2G0wxh8zEznslfYt_1XtKbNlnbAaxwwTfom2_R1MNu9xe73r5tNAoLFtsUuWzqXCuJj8qAxbfRPDuecbN6-2Zye5RcfV-9Olxe5LYRkuRPOOupLU6tKGlo0tRFCclYapspGOgdepavkzlAuPBhVM-CUGlMUIGs-Jy-m2l3ov48-DnqL0fq2NZ3vx6iVopxDiszJYgJt6GMMvtG7gFsT9pqCvjOnkzn9x1wKPDs0j_XWuyN-UJXmzw9zE5OeJpjOYjxiBS3KCqqEVRP2A1u__8-j-vzT-q8V8imLcfA_j1kTvmmpuBL6y4eVLl-vPl_S9Xt9mfhy4n0Sfo0-6GjRd9Y7DN4O2vX4r9_eAt1cqVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77133020</pqid></control><display><type>article</type><title>Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Huh, Kyongsang ; Schentag, Jerome J. ; Wilton, John H. ; Nix, David E.</creator><creatorcontrib>Huh, Kyongsang ; Schentag, Jerome J. ; Wilton, John H. ; Nix, David E.</creatorcontrib><description>Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On the basis of mass, infrared, and proton magnetic resonance spectra, the major adducts appeared to be amides formed by an attack of the B‐lactam carbonyl group of ticarcillin by an amino group of tobramycin. All other moieties of ticarcillin were intact except that the β‐lactam ring was opened and was rotated by 120–130°. The minimum inhibitory concentrations (MICs) of the adducts, tobramycin, and ticarcillin were 20.0, 0.25, and 2.0 μg/mL forStaphylococcus aureusandEscherichia coli, and 160.0, 0.5, and 8.0 μg/mL forPseudomonas aeruginosa.Thus, the major adducts possessed some antimicrobial activity, but not enough to be active in the treatment of infections. As shown by fluorescence polarization immunoassay (FPIA), the adducts demonstrate some cross‐reactivity in the assay of tobramycin. However, it was insufficient to cause significant error in the measurement of tobramycin in human serum.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.2600830602</identifier><identifier>PMID: 9120803</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Washington: Elsevier Inc</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacteria - drug effects ; Biological and medical sciences ; Cross Reactions ; Humans ; Medical sciences ; Penicillins - pharmacology ; Pharmacology. Drug treatments ; Spectrophotometry ; Ticarcillin - chemistry ; Ticarcillin - pharmacology ; Tobramycin - chemistry ; Tobramycin - pharmacology</subject><ispartof>Journal of pharmaceutical sciences, 1994-06, Vol.83 (6), p.763-767</ispartof><rights>1994 Wiley-Liss, Inc., A Wiley Company</rights><rights>Copyright © 1994 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4562-d5dcd1e8ab796a14fba556328a278f6dd0e763263da135e0a7b20311aa4406b3</citedby><cites>FETCH-LOGICAL-c4562-d5dcd1e8ab796a14fba556328a278f6dd0e763263da135e0a7b20311aa4406b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.2600830602$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.2600830602$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4148909$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9120803$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huh, Kyongsang</creatorcontrib><creatorcontrib>Schentag, Jerome J.</creatorcontrib><creatorcontrib>Wilton, John H.</creatorcontrib><creatorcontrib>Nix, David E.</creatorcontrib><title>Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On the basis of mass, infrared, and proton magnetic resonance spectra, the major adducts appeared to be amides formed by an attack of the B‐lactam carbonyl group of ticarcillin by an amino group of tobramycin. All other moieties of ticarcillin were intact except that the β‐lactam ring was opened and was rotated by 120–130°. The minimum inhibitory concentrations (MICs) of the adducts, tobramycin, and ticarcillin were 20.0, 0.25, and 2.0 μg/mL forStaphylococcus aureusandEscherichia coli, and 160.0, 0.5, and 8.0 μg/mL forPseudomonas aeruginosa.Thus, the major adducts possessed some antimicrobial activity, but not enough to be active in the treatment of infections. As shown by fluorescence polarization immunoassay (FPIA), the adducts demonstrate some cross‐reactivity in the assay of tobramycin. However, it was insufficient to cause significant error in the measurement of tobramycin in human serum.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacteria - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cross Reactions</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Penicillins - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Spectrophotometry</subject><subject>Ticarcillin - chemistry</subject><subject>Ticarcillin - pharmacology</subject><subject>Tobramycin - chemistry</subject><subject>Tobramycin - pharmacology</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM2O0zAURi0EGkphyw4pC8Qu5dqO7WRZBugwzPCjVmJpObaD7pAmxU4GuuMR5hl5kvEoVRELxMqy7vk-Xx9CnlJYUAD28moXF0wClBwksHtkRgWDXAJV98ksASznoqgekkcxXgEkRogTclJRBiXwGTlbD2G0wxh8zEznslfYt_1XtKbNlnbAaxwwTfom2_R1MNu9xe73r5tNAoLFtsUuWzqXCuJj8qAxbfRPDuecbN6-2Zye5RcfV-9Olxe5LYRkuRPOOupLU6tKGlo0tRFCclYapspGOgdepavkzlAuPBhVM-CUGlMUIGs-Jy-m2l3ov48-DnqL0fq2NZ3vx6iVopxDiszJYgJt6GMMvtG7gFsT9pqCvjOnkzn9x1wKPDs0j_XWuyN-UJXmzw9zE5OeJpjOYjxiBS3KCqqEVRP2A1u__8-j-vzT-q8V8imLcfA_j1kTvmmpuBL6y4eVLl-vPl_S9Xt9mfhy4n0Sfo0-6GjRd9Y7DN4O2vX4r9_eAt1cqVQ</recordid><startdate>199406</startdate><enddate>199406</enddate><creator>Huh, Kyongsang</creator><creator>Schentag, Jerome J.</creator><creator>Wilton, John H.</creator><creator>Nix, David E.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199406</creationdate><title>Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts</title><author>Huh, Kyongsang ; Schentag, Jerome J. ; Wilton, John H. ; Nix, David E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4562-d5dcd1e8ab796a14fba556328a278f6dd0e763263da135e0a7b20311aa4406b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacteria - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cross Reactions</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Penicillins - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Spectrophotometry</topic><topic>Ticarcillin - chemistry</topic><topic>Ticarcillin - pharmacology</topic><topic>Tobramycin - chemistry</topic><topic>Tobramycin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huh, Kyongsang</creatorcontrib><creatorcontrib>Schentag, Jerome J.</creatorcontrib><creatorcontrib>Wilton, John H.</creatorcontrib><creatorcontrib>Nix, David E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huh, Kyongsang</au><au>Schentag, Jerome J.</au><au>Wilton, John H.</au><au>Nix, David E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>1994-06</date><risdate>1994</risdate><volume>83</volume><issue>6</issue><spage>763</spage><epage>767</epage><pages>763-767</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On the basis of mass, infrared, and proton magnetic resonance spectra, the major adducts appeared to be amides formed by an attack of the B‐lactam carbonyl group of ticarcillin by an amino group of tobramycin. All other moieties of ticarcillin were intact except that the β‐lactam ring was opened and was rotated by 120–130°. The minimum inhibitory concentrations (MICs) of the adducts, tobramycin, and ticarcillin were 20.0, 0.25, and 2.0 μg/mL forStaphylococcus aureusandEscherichia coli, and 160.0, 0.5, and 8.0 μg/mL forPseudomonas aeruginosa.Thus, the major adducts possessed some antimicrobial activity, but not enough to be active in the treatment of infections. As shown by fluorescence polarization immunoassay (FPIA), the adducts demonstrate some cross‐reactivity in the assay of tobramycin. However, it was insufficient to cause significant error in the measurement of tobramycin in human serum.</abstract><cop>Washington</cop><pub>Elsevier Inc</pub><pmid>9120803</pmid><doi>10.1002/jps.2600830602</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 1994-06, Vol.83 (6), p.763-767
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_77133020
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Anti-Bacterial Agents - pharmacology
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacteria - drug effects
Biological and medical sciences
Cross Reactions
Humans
Medical sciences
Penicillins - pharmacology
Pharmacology. Drug treatments
Spectrophotometry
Ticarcillin - chemistry
Ticarcillin - pharmacology
Tobramycin - chemistry
Tobramycin - pharmacology
title Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T09%3A50%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structures%20and%20Biological%20Activities%20of%20Tobramycin%E2%80%90Ticarcillin%20Adducts&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Huh,%20Kyongsang&rft.date=1994-06&rft.volume=83&rft.issue=6&rft.spage=763&rft.epage=767&rft.pages=763-767&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.2600830602&rft_dat=%3Cproquest_cross%3E77133020%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77133020&rft_id=info:pmid/9120803&rft_els_id=S0022354915494985&rfr_iscdi=true